Single plant derived nanotechnology for synergistic antibacterial therapies

Research output: Contribution to journalArticle

Standard

Single plant derived nanotechnology for synergistic antibacterial therapies. / Kalluri, Jhansi R.; Gonzalez-Rodriguez, Roberto; Hartman, Phil S.; Loni, Armando; Canham, Leigh T.; Coffer, Jeffery L.

In: PLoS ONE, Vol. 11, No. 9, e0163270, 29.09.2016.

Research output: Contribution to journalArticle

Harvard

Kalluri, JR, Gonzalez-Rodriguez, R, Hartman, PS, Loni, A, Canham, LT & Coffer, JL 2016, 'Single plant derived nanotechnology for synergistic antibacterial therapies', PLoS ONE, vol. 11, no. 9, e0163270. https://doi.org/10.1371/journal.pone.0163270

APA

Kalluri, J. R., Gonzalez-Rodriguez, R., Hartman, P. S., Loni, A., Canham, L. T., & Coffer, J. L. (2016). Single plant derived nanotechnology for synergistic antibacterial therapies. PLoS ONE, 11(9), [e0163270]. https://doi.org/10.1371/journal.pone.0163270

Vancouver

Kalluri JR, Gonzalez-Rodriguez R, Hartman PS, Loni A, Canham LT, Coffer JL. Single plant derived nanotechnology for synergistic antibacterial therapies. PLoS ONE. 2016 Sep 29;11(9). e0163270. https://doi.org/10.1371/journal.pone.0163270

Author

Kalluri, Jhansi R. ; Gonzalez-Rodriguez, Roberto ; Hartman, Phil S. ; Loni, Armando ; Canham, Leigh T. ; Coffer, Jeffery L. / Single plant derived nanotechnology for synergistic antibacterial therapies. In: PLoS ONE. 2016 ; Vol. 11, No. 9.

Bibtex

@article{3af5d805e7214c9da9fec3de32baa82b,
title = "Single plant derived nanotechnology for synergistic antibacterial therapies",
abstract = "Multiple new approaches to tackle multidrug resistant infections are urgently needed and under evaluation. One nanotechnology-based approach to delivering new relevant therapeutics involves silicon accumulator plants serving as a viable silicon source in green routes for the fabrication of the nanoscale drug delivery carrier porous silicon (pSi). If the selected plant leaf components contain medicinally-active species as well, then a single substance can provide not only the nanoscale high surface area drug delivery carrier, but the drug itself. With this idea in mind, porous silicon was fabricated from joints of the silicon accumulator plant Bambuseae (Tabasheer) and loaded with an antibacterial extract originating from leaves of the same type of plant (Bambuseae arundinacea). Preparation of porous silicon from Tabasheer includes extraction of biogenic silica from the ground plant by calcination, followed by reduction with magnesium in the presence of sodium chloride, thereby acting as a thermal moderator that helps to retain the mesoporous structure of the feedstock. The purified product was characterized by a combination of scanning electron microscopy (SEM), energy dispersive X-ray analysis (EDX), X-ray diffraction (XRD), Raman spectroscopy, transmission electron microscopy (TEM), and low temperature nitrogen gas adsorption measurements. Antimicrobial activity and minimum inhibitory concentration of a leaf extract of Bambuseae arundinacea was tested against the bacteria Escherichia Coli (E. Coli) and Staphylococcus aureus (S. Aureus), along with the fungus Candida albicans (C. Albicans). A S. aureus active ethanolic leaf extract was loaded into the above Tabasheer-derived porous silicon. Initial studies indicate sustained in vitro antibacterial activity of the extract-loaded plant derived pSi (25 wt %, TGA), as measured by disk diffusion inhibitory zone assays. Subsequent chromatographic separation of this extract revealed that the active antimicrobial species present include stigmasterol and 2,6-dimethoxy-p-benzoquinone.",
author = "Kalluri, {Jhansi R.} and Roberto Gonzalez-Rodriguez and Hartman, {Phil S.} and Armando Loni and Canham, {Leigh T.} and Coffer, {Jeffery L.}",
year = "2016",
month = sep,
day = "29",
doi = "10.1371/journal.pone.0163270",
language = "English",
volume = "11",
journal = "PLoSONE",
issn = "1932-6203",
publisher = "Public Library of Science (PLOS)",
number = "9",

}

RIS

TY - JOUR

T1 - Single plant derived nanotechnology for synergistic antibacterial therapies

AU - Kalluri, Jhansi R.

AU - Gonzalez-Rodriguez, Roberto

AU - Hartman, Phil S.

AU - Loni, Armando

AU - Canham, Leigh T.

AU - Coffer, Jeffery L.

PY - 2016/9/29

Y1 - 2016/9/29

N2 - Multiple new approaches to tackle multidrug resistant infections are urgently needed and under evaluation. One nanotechnology-based approach to delivering new relevant therapeutics involves silicon accumulator plants serving as a viable silicon source in green routes for the fabrication of the nanoscale drug delivery carrier porous silicon (pSi). If the selected plant leaf components contain medicinally-active species as well, then a single substance can provide not only the nanoscale high surface area drug delivery carrier, but the drug itself. With this idea in mind, porous silicon was fabricated from joints of the silicon accumulator plant Bambuseae (Tabasheer) and loaded with an antibacterial extract originating from leaves of the same type of plant (Bambuseae arundinacea). Preparation of porous silicon from Tabasheer includes extraction of biogenic silica from the ground plant by calcination, followed by reduction with magnesium in the presence of sodium chloride, thereby acting as a thermal moderator that helps to retain the mesoporous structure of the feedstock. The purified product was characterized by a combination of scanning electron microscopy (SEM), energy dispersive X-ray analysis (EDX), X-ray diffraction (XRD), Raman spectroscopy, transmission electron microscopy (TEM), and low temperature nitrogen gas adsorption measurements. Antimicrobial activity and minimum inhibitory concentration of a leaf extract of Bambuseae arundinacea was tested against the bacteria Escherichia Coli (E. Coli) and Staphylococcus aureus (S. Aureus), along with the fungus Candida albicans (C. Albicans). A S. aureus active ethanolic leaf extract was loaded into the above Tabasheer-derived porous silicon. Initial studies indicate sustained in vitro antibacterial activity of the extract-loaded plant derived pSi (25 wt %, TGA), as measured by disk diffusion inhibitory zone assays. Subsequent chromatographic separation of this extract revealed that the active antimicrobial species present include stigmasterol and 2,6-dimethoxy-p-benzoquinone.

AB - Multiple new approaches to tackle multidrug resistant infections are urgently needed and under evaluation. One nanotechnology-based approach to delivering new relevant therapeutics involves silicon accumulator plants serving as a viable silicon source in green routes for the fabrication of the nanoscale drug delivery carrier porous silicon (pSi). If the selected plant leaf components contain medicinally-active species as well, then a single substance can provide not only the nanoscale high surface area drug delivery carrier, but the drug itself. With this idea in mind, porous silicon was fabricated from joints of the silicon accumulator plant Bambuseae (Tabasheer) and loaded with an antibacterial extract originating from leaves of the same type of plant (Bambuseae arundinacea). Preparation of porous silicon from Tabasheer includes extraction of biogenic silica from the ground plant by calcination, followed by reduction with magnesium in the presence of sodium chloride, thereby acting as a thermal moderator that helps to retain the mesoporous structure of the feedstock. The purified product was characterized by a combination of scanning electron microscopy (SEM), energy dispersive X-ray analysis (EDX), X-ray diffraction (XRD), Raman spectroscopy, transmission electron microscopy (TEM), and low temperature nitrogen gas adsorption measurements. Antimicrobial activity and minimum inhibitory concentration of a leaf extract of Bambuseae arundinacea was tested against the bacteria Escherichia Coli (E. Coli) and Staphylococcus aureus (S. Aureus), along with the fungus Candida albicans (C. Albicans). A S. aureus active ethanolic leaf extract was loaded into the above Tabasheer-derived porous silicon. Initial studies indicate sustained in vitro antibacterial activity of the extract-loaded plant derived pSi (25 wt %, TGA), as measured by disk diffusion inhibitory zone assays. Subsequent chromatographic separation of this extract revealed that the active antimicrobial species present include stigmasterol and 2,6-dimethoxy-p-benzoquinone.

U2 - 10.1371/journal.pone.0163270

DO - 10.1371/journal.pone.0163270

M3 - Article

AN - SCOPUS:84991780908

VL - 11

JO - PLoSONE

JF - PLoSONE

SN - 1932-6203

IS - 9

M1 - e0163270

ER -